← Back to Clinical Trials
Recruiting NCT07101796

NCT07101796 Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07101796
Status Recruiting
Phase
Sponsor Peking University First Hospital
Condition Personality
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-09-14
Primary Completion 2025-08

Trial Parameters

Condition Personality
Sponsor Peking University First Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2024-09-14
Completion 2025-08
Interventions
continous positive airway pressure (CPAP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.

Eligibility Criteria

Inclusion Criteria: * Age: 18\~70 years old * Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration. * Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently; * The patients gave informed consent to the study and cooperated with relevant treatment and evaluation. Exclusion Criteria: * Age below 18 or above 70 years old * No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA * lacking full independence in behavior and cognitive ability, unable to answer questions independently * Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology